Agranulocytosis after Metamizole Sodium Use
Metamizole sodium (Novalgine) is commonly used as an antipyretic, analgesic, and spasmolytic agent in some parts of the world and our country; however, it is banned in developed countries because of severe side effects. Here we present a case of a three-years- four- months-old girl who developed lif...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cukurova University
2015-09-01
|
Series: | Çukurova Üniversitesi Tıp Fakültesi Dergisi |
Subjects: | |
Online Access: | http://www.scopemed.org/fulltextpdf.php?mno=166170 |
id |
doaj-0df1f626a3014d758759b897d2f66e44 |
---|---|
record_format |
Article |
spelling |
doaj-0df1f626a3014d758759b897d2f66e442020-11-24T23:58:05ZengCukurova UniversityÇukurova Üniversitesi Tıp Fakültesi Dergisi0250-51502015-09-01403580583166170Agranulocytosis after Metamizole Sodium UseEren Cagan0Havva Hasret Cagan1Duygu Surmelihindi2Gaziantep Cocuk Hastanesi, Cocuk Enfeksiyon Hastaliklari Uzmani, Gaziantep sevket Yilmaz Egitim ve Arastirma Hastanesi, Cocuk Alerji ve immunolojisi Uzmani, Bursa Gaziantep Cocuk Hastanesi, Cocuk Sagligi ve Hastaliklari Uzmani, GaziantepMetamizole sodium (Novalgine) is commonly used as an antipyretic, analgesic, and spasmolytic agent in some parts of the world and our country; however, it is banned in developed countries because of severe side effects. Here we present a case of a three-years- four- months-old girl who developed life-threatening agranulocytosis in his bone marrow after metamizole sodium use for fever, which resolved with granulocyte colony-stimulating factor therapy. [Cukurova Med J 2015; 40(3.000): 580-583]http://www.scopemed.org/fulltextpdf.php?mno=166170AgranulocytosisMetamizoleChildFever |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eren Cagan Havva Hasret Cagan Duygu Surmelihindi |
spellingShingle |
Eren Cagan Havva Hasret Cagan Duygu Surmelihindi Agranulocytosis after Metamizole Sodium Use Çukurova Üniversitesi Tıp Fakültesi Dergisi Agranulocytosis Metamizole Child Fever |
author_facet |
Eren Cagan Havva Hasret Cagan Duygu Surmelihindi |
author_sort |
Eren Cagan |
title |
Agranulocytosis after Metamizole Sodium Use |
title_short |
Agranulocytosis after Metamizole Sodium Use |
title_full |
Agranulocytosis after Metamizole Sodium Use |
title_fullStr |
Agranulocytosis after Metamizole Sodium Use |
title_full_unstemmed |
Agranulocytosis after Metamizole Sodium Use |
title_sort |
agranulocytosis after metamizole sodium use |
publisher |
Cukurova University |
series |
Çukurova Üniversitesi Tıp Fakültesi Dergisi |
issn |
0250-5150 |
publishDate |
2015-09-01 |
description |
Metamizole sodium (Novalgine) is commonly used as an antipyretic, analgesic, and spasmolytic agent in some parts of the world and our country; however, it is banned in developed countries because of severe side effects. Here we present a case of a three-years- four- months-old girl who developed life-threatening agranulocytosis in his bone marrow after metamizole sodium use for fever, which resolved with granulocyte colony-stimulating factor therapy. [Cukurova Med J 2015; 40(3.000): 580-583] |
topic |
Agranulocytosis Metamizole Child Fever |
url |
http://www.scopemed.org/fulltextpdf.php?mno=166170 |
work_keys_str_mv |
AT erencagan agranulocytosisaftermetamizolesodiumuse AT havvahasretcagan agranulocytosisaftermetamizolesodiumuse AT duygusurmelihindi agranulocytosisaftermetamizolesodiumuse |
_version_ |
1725452053183987712 |